160 related articles for article (PubMed ID: 1676988)
1. c-erbB-2 proto-oncogene expression and its relationship to survival in gastric carcinoma: an immunohistochemical study on archival material.
Jain S; Filipe MI; Gullick WJ; Linehan J; Morris RW
Int J Cancer; 1991 Jul; 48(5):668-71. PubMed ID: 1676988
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival.
Tsugawa K; Fushida S; Yonemura Y
Oncology; 1993; 50(6):418-25. PubMed ID: 7901825
[TBL] [Abstract][Full Text] [Related]
4. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection.
Motojima K; Furui J; Kohara N; Izawa K; Kanematsu T; Shiku H
Surgery; 1994 Mar; 115(3):349-54. PubMed ID: 7907434
[TBL] [Abstract][Full Text] [Related]
5. Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.
Jaehne J; Urmacher C; Thaler HT; Friedlander-Klar H; Cordon-Cardo C; Meyer HJ
J Cancer Res Clin Oncol; 1992; 118(6):474-9. PubMed ID: 1352299
[TBL] [Abstract][Full Text] [Related]
6. c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis.
Schroeter CA; De Potter CR; Rathsmann K; Willighagen RG; Greep JC
Br J Cancer; 1992 Oct; 66(4):728-34. PubMed ID: 1358163
[TBL] [Abstract][Full Text] [Related]
7. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.
Wright C; Nicholson S; Angus B; Sainsbury JR; Farndon J; Cairns J; Harris AL; Horne CH
Br J Cancer; 1992 Jan; 65(1):118-21. PubMed ID: 1346366
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.
Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 oncogene product expression and prognosis in gastric carcinoma.
Hilton DA; West KP
J Clin Pathol; 1992 May; 45(5):454-6. PubMed ID: 1350789
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer.
Horiguchi J; Iino Y; Takei H; Yokoe T; Ishida T; Morishita Y
Oncology; 1994; 51(1):47-51. PubMed ID: 7903441
[TBL] [Abstract][Full Text] [Related]
11. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.
Lemoine NR; Jain S; Silvestre F; Lopes C; Hughes CM; McLelland E; Gullick WJ; Filipe MI
Br J Cancer; 1991 Jul; 64(1):79-83. PubMed ID: 1677259
[No Abstract] [Full Text] [Related]
12. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
[TBL] [Abstract][Full Text] [Related]
13. c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma.
Collier JD; Guo K; Mathew J; May FE; Bennett MK; Corbett IP; Bassendine MF; Burt AD
J Hepatol; 1992 Mar; 14(2-3):377-80. PubMed ID: 1380026
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma.
Yonemura Y; Ninomiya I; Ohoyama S; Kimura H; Yamaguchi A; Fushida S; Kosaka T; Miwa K; Miyazaki I; Endou Y
Cancer; 1991 Jun; 67(11):2914-8. PubMed ID: 1673870
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-erbB-2 gene in human head and neck carcinoma.
Craven JM; Pavelic ZP; Stambrook PJ; Pavelic L; Gapany M; Kelley DJ; Gapany S; Gluckman JL
Anticancer Res; 1992; 12(6B):2273-6. PubMed ID: 1363518
[TBL] [Abstract][Full Text] [Related]
16. Amplification and overexpression of the c-erbB-2 protooncogene in human gastric cancer.
Sasaki K; Tomita Y; Azuma M; Shida S; Simizu B
Gastroenterol Jpn; 1992 Apr; 27(2):172-8. PubMed ID: 1577221
[TBL] [Abstract][Full Text] [Related]
17. C-erbB-2 expression in squamous cell carcinoma of the head and neck.
Field JK; Spandidos DA; Yiagnisis M; Gosney JR; Papadimitriou K; Stell PM
Anticancer Res; 1992; 12(3):613-9. PubMed ID: 1377893
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of c-erbB-2 protein in gastric carcinomas and lymph-node metastases: is the c-erbB-2 protein really a prognostic indicator?
Ohguri T; Sato Y; Koizumi W; Saigenji K; Kameya T
Int J Cancer; 1993 Jan; 53(1):75-9. PubMed ID: 8093216
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.
Walker RA; Gullick WJ; Varley JM
Br J Cancer; 1989 Sep; 60(3):426-9. PubMed ID: 2571356
[TBL] [Abstract][Full Text] [Related]
20. Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells.
Sasano H; Date F; Imatani A; Asaki S; Nagura H
Hum Pathol; 1993 Jun; 24(6):584-9. PubMed ID: 8099338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
